231 related articles for article (PubMed ID: 28608155)
1. Pathophysiology of Gastric NETs: Role of Gastrin and Menin.
Sundaresan S; Kang AJ; Merchant JL
Curr Gastroenterol Rep; 2017 Jul; 19(7):32. PubMed ID: 28608155
[TBL] [Abstract][Full Text] [Related]
2. Deletion of
Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
4. Hypergastrinemia Expands Gastric ECL Cells Through CCK2R
Sheng W; Malagola E; Nienhüser H; Zhang Z; Kim W; Zamechek L; Sepulveda A; Hata M; Hayakawa Y; Zhao CM; Chen D; Wang TC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):434-449.e1. PubMed ID: 32330731
[TBL] [Abstract][Full Text] [Related]
5. Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.
Lloyd KA; Moore AR; Parsons BN; O'Hara A; Boyce M; Dockray GJ; Varro A; Pritchard DM
Oncotarget; 2016 Jul; 7(29):45462-45478. PubMed ID: 27323780
[TBL] [Abstract][Full Text] [Related]
6. Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia.
Higham AD; Bishop LA; Dimaline R; Blackmore CG; Dobbins AC; Varro A; Thompson DG; Dockray GJ
Gastroenterology; 1999 Jun; 116(6):1310-8. PubMed ID: 10348814
[TBL] [Abstract][Full Text] [Related]
7. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
[TBL] [Abstract][Full Text] [Related]
8. Gastrin Induces Nuclear Export and Proteasome Degradation of Menin in Enteric Glial Cells.
Sundaresan S; Meininger CA; Kang AJ; Photenhauer AL; Hayes MM; Sahoo N; Grembecka J; Cierpicki T; Ding L; Giordano TJ; Else T; Madrigal DJ; Low MJ; Campbell F; Baker AM; Xu H; Wright NA; Merchant JL
Gastroenterology; 2017 Dec; 153(6):1555-1567.e15. PubMed ID: 28859856
[TBL] [Abstract][Full Text] [Related]
9. Relationship of ECL cells and gastric neoplasia.
Waldum HL; Brenna E; Sandvik AK
Yale J Biol Med; 1998; 71(3-4):325-35. PubMed ID: 10461363
[TBL] [Abstract][Full Text] [Related]
10. Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling.
Varro A; Kenny S; Hemers E; McCaig C; Przemeck S; Wang TC; Bodger K; Pritchard DM
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1133-40. PubMed ID: 17218472
[TBL] [Abstract][Full Text] [Related]
11. Importance of gastrin in the pathogenesis and treatment of gastric tumors.
Burkitt MD; Varro A; Pritchard DM
World J Gastroenterol; 2009 Jan; 15(1):1-16. PubMed ID: 19115463
[TBL] [Abstract][Full Text] [Related]
12. Histamine metabolism of gastric carcinoids in Mastomys natalensis.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Nilsson O
Yale J Biol Med; 1998; 71(3-4):207-15. PubMed ID: 10461353
[TBL] [Abstract][Full Text] [Related]
13. Serum gastrin and gastric enterochromaffin-like cells during estrous cycle, pregnancy and lactation, and in response to estrogen-like agents in rats.
Vigen RA; Chen D; Syversen U; Stunes K; Hakanson R; Zhao CM
J Physiol Pharmacol; 2011 Jun; 62(3):335-40. PubMed ID: 21893694
[TBL] [Abstract][Full Text] [Related]
14. Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor.
Pritchard DM; Berry D; Przemeck SM; Campbell F; Edwards SW; Varro A
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G798-805. PubMed ID: 18719002
[TBL] [Abstract][Full Text] [Related]
15. Histidine decarboxylase expression and histamine metabolism in gastric oxyntic mucosa during hypergastrinemia and carcinoid tumor formation.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Granérus G; Theodorsson E; Nilsson O
Endocrinology; 1996 Oct; 137(10):4435-42. PubMed ID: 8828505
[TBL] [Abstract][Full Text] [Related]
16. p21 and p27 immunoexpression in gastric well differentiated endocrine tumors (ECL-cell carcinoids).
Doganavsargil B; Sarsik B; Kirdok FS; Musoglu A; Tuncyurek M
World J Gastroenterol; 2006 Oct; 12(39):6280-4. PubMed ID: 17072949
[TBL] [Abstract][Full Text] [Related]
17. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd KA; Parsons BN; Burkitt MD; Moore AR; Papoutsopoulou S; Boyce M; Duckworth CA; Exarchou K; Howes N; Rainbow L; Fang Y; Oxvig C; Dodd S; Varro A; Hall N; Pritchard DM
Cell Mol Gastroenterol Hepatol; 2020; 10(1):113-132. PubMed ID: 32004755
[TBL] [Abstract][Full Text] [Related]
18. The role of endogenous gastrin in the development of enterochromaffin-like cell carcinoid tumors in Mastomys natalensis: a study with the specific gastrin receptor antagonist AG-041R.
Chiba T; Kinoshita Y; Sawada M; Kishi K; Baba A; Hoshino E
Yale J Biol Med; 1998; 71(3-4):247-55. PubMed ID: 10461356
[TBL] [Abstract][Full Text] [Related]
19. Gastric carcinoid expresses the gastrin autocrine pathway.
Smith AM; Watson SA; Caplin M; Clarke P; Griffin N; Varro A; Hardcastle JD
Br J Surg; 1998 Sep; 85(9):1285-9. PubMed ID: 9752879
[TBL] [Abstract][Full Text] [Related]
20. Gastrin and the enterochromaffin-like cell: an acid update.
Kidd M; Modlin IM; Tang LH
Dig Surg; 1998; 15(3):209-17. PubMed ID: 9845587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
